Pertuzumab & Herceptin Plus Chemotherapy Significantly Improved the Rate of Complete Tumour Disappearance

Roche announced results from the NEOSPHERE trial, a Phase II neoadjuvant study evaluating the effect of a novel combination regimen of pertuzumab and Herceptin (trastuzumab) plus chemotherapy (docetaxel) in women with early-stage HER2-positive breast cancer। The data, presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), showed that the two antibodies plus docetaxel given in the neoadjuvant setting prior to surgery significantly improved the rate of complete tumour disappearance (pathological complete response rate, pCR, of 45.8 percent) in the breast by more than half compared to Herceptin plus docetaxel (pCR of 29. 0 percent), p=0.014.

More....

GE Healthcare Expands InSite OnWatch Capabilities for MRI Systems, Helping Enable Greater Efficiencies and Improving Customer Experience

WAUKESHA, WI – GE Healthcare, a unit of General Electric, is expanding InSite OnWatch capabilities, a feature of GE’s AssurePoint^™ Services portfolio for MRI systems. Unplanned downtime from clinical equipment can negatively affect virtually every aspect of care delivery — from patient care to staff productivity and cost control। InSite OnWatch, available only with GE’s AssurePoint Rapid and AssurePoint Performance service offerings (US and Canada only), can remotely resolve performance issues and forecast maintenance needs to reduce unplanned downtime — improving efficiencies and helping to lower the cost of care।

More...http://bit.ly/gcaMww

Ohio Hospital System Becomes 100th to Implement McKesson's Paragon HIS

McKesson announced that its Paragon healthcare information solution is now in use by more than 100 hospitals and health systems across the United States and Puerto Rico। Community Hospitals and Wellness Centers (CHWC), a three-facility system based in Bryan, Ohio, recently became the 100th hospital to go live with the integrated financial and clinical software system. With a small information technology staff, the hospital sought a comprehensive yet affordable HIS with the functionality to integrate patient data and revenue cycle information using one platform.

More....http://bit.ly/i9i7B2

Philips and Definiens Begin Developing Digital Pathology Image Analysis Solutions for Cancer Diagnositcs

Munich, Germany / Washington, D.C. – Royal Philips Electronics andDefiniens, the number one Health Image IntelligenceTM company, announced the companies have signed a cooperation agreement to jointly develop a digital pathology system to support clinical diagnosis of several types of cancer, beginning with breast cancer। The companies will integrate Definiens’ image analysis solutions into Philips’ comprehensive imaging systems, providing pathologists with tools for assessment of immunohistochemically stained cancer tissue.

More: http://bit.ly/hvCyjJ